Feature Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine By Shelley Wood
News • Interventional EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE By Todd Neale January 15, 2021
News CAC Screening Cost-effective for Statin Decisions in Hereditary CAD The test isn’t widely reimbursed, but cost analysis suggests it is “economically prudent,” say researchers. By Michael O'Riordan January 14, 2021
News COVID-19: TCTMD’s Daily Dispatch for January 14 WHO officials visiting China catch COVID-19, new US variants, RAAS inhibitor support, immunity post-infection, and more. By Todd Neale January 14, 2021
News REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients Along with BRACE CORONA, there are now two RCTs showing no impact on outcomes when maintaining ACE inhibitors and ARBs. By Todd Neale January 13, 2021
News • Interventional Even Very Low Alcohol Consumption Ups AF Risk A community-based study of more than 100,000 people provides “solid evidence,” editorialists say, but still leaves open questions. By Caitlin E. Cox January 13, 2021
News • Interventional New Tool Helps Balance Bleeding and Thrombotic Risks After PCI Researchers say their two models are being incorporated into a mobile application that should launch in the next few weeks. By Yael L. Maxwell January 13, 2021
News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Two studies reveal the pandemic’s impact on CV mortality in the US and a global drop in diagnostics that could spell future trouble. By Michael O'Riordan January 12, 2021
News • Interventional FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited Acknowledging the recent, reassuring SWEDEPAD data, the agency says it’s not yet ready to update its advice to doctors. By L.A. McKeown January 12, 2021
Feature Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave Editors grappled with study volume and quality but wanted to publish something—ANYTHING—on the virus’s CV effects. By Michael O'Riordan January 11, 2021
News ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care From medication decisions to referral issues and costs, the committee focused on streamlining science and assistance. By L.A. McKeown January 11, 2021
News • Interventional How to Resume Elective CV Interventions as COVID-19 Rages On An EAPCI document offers advice on how to prioritize procedures and do them safely as the pandemic moves past its first wave. By Caitlin E. Cox January 11, 2021